Use of pkc inhibitors for the manufacture of a medicament...

Details Use of pkc inhibitors for the manufacture of a medicament... Use of pkc inhibitors for the manufacture of a medicament...

A - Human Necessities

61

K

A61K 31/40 (2006.01) A61K 31/00 (2006.01) A61K 31/407 (2006.01)

Patent

CA 2323176

Methods for inhibiting activation and/or proliferation of T cells and B cells and for treating autoimmune diseases and/or disease manifestations are disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4- [N,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'- indolyl)]-1(H)-pyrrole-2,5-dione and its pharmaceutically acceptable salts.

Cette invention se rapporte à des procédés servant à inhiber l'activation et/ou la prolifération de lymphocytes T et de lymphocytes B et servant à traiter les maladies auto-immunes et/ou des manifestations pathologiques de ces maladies, notamment en utilisant l'inhibiteur de protéine-kinase C (PKC) à sélectivité pour les isozymes, (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione et ses sels acceptables sur le plan pharmaceutique.

Affiliated with

Also associated with

Rating

Use of pkc inhibitors for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pkc inhibitors for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pkc inhibitors for the manufacture of a medicament... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1744895